Meridian Menu Expansion of Antigens, Antibodies for Tropical Diseases
Meridian Bioscience has launched an expansion of its antigens and antibodies menu for emerging Tropical diseases, such as zika. The expanded menu includes over 150 biologicals consisting of native, recombinant antigens and antibodies. The biologicals have already been used in diagnostic assays for zika, dengue, chikungunya, malaria, lyme, leptospirosis, leishmaniasis, and chagas, the company said. These assays have also obtained US Food and Drug Administration, ANVISA, and CE approvals, it added.